- Home
- WINA vs CLDX Comparison
WINA vs CLDX Comparison
Compare WINA & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WINA | CLDX |
|---|---|---|
| Founded | 1988 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2006 | 1995 |
Fundamental Metrics
Financial Performance| Metric | WINA | CLDX |
|---|---|---|
| Price | $418.13 | $30.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $44.50 |
| AVG Volume (30 Days) | 64.6K | ★ 818.1K |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | ★ 3.76 | N/A |
| EPS | ★ 11.30 | N/A |
| Revenue | ★ $86,055,700.00 | $12,743,000.00 |
| Revenue This Year | $5.55 | $111.39 |
| Revenue Next Year | $6.03 | $235.85 |
| P/E Ratio | $37.98 | ★ N/A |
| Revenue Growth | 5.86 | ★ 87.78 |
| 52 Week Low | $295.79 | $14.40 |
| 52 Week High | $526.81 | $34.52 |
Technical Indicators
Market Signals| Indicator | WINA | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 54.64 |
| Support Level | $405.17 | $28.25 |
| Resistance Level | $451.93 | $30.90 |
| Average True Range (ATR) | 19.63 | 1.52 |
| MACD | -1.60 | -0.06 |
| Stochastic Oscillator | 20.69 | 36.74 |
Price Performance
Historical ComparisonAbout WINA Winmark Corporation
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.